Table of Content

1 Parkinson's Disease Drug Market Introduction and Overview
1.1 Parkinson's Disease Drug Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Parkinson's Disease Drug Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Parkinson's Disease Drug Revenue and Market Share by Type
3 Global Parkinson's Disease Drug Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Parkinson's Disease Drug Revenue Market Share by Application (2019-2024)
4 Global Market Growth Trends Analysis
4.1 Global Parkinson's Disease Drug Market Size (2019-2024)
4.2 Parkinson's Disease Drug Growth Trends Analysis by Regions
4.2.1 Parkinson's Disease Drug Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Parkinson's Disease Drug Historic Revenue Market Size by Regions (2019-2024)
4.2.3 North America Parkinson's Disease Drug Market Size (2019-2024)
4.2.4 Europe Parkinson's Disease Drug Market Size (2019-2024)
4.2.5 Asia-Pacific Parkinson's Disease Drug Market Size (2019-2024)
4.2.6 Latin America Parkinson's Disease Drug Market Size (2019-2024)
4.2.7 Middle East & Africa Parkinson's Disease Drug Market Size (2019-2024)
5 North America
5.1 North America Parkinson's Disease Drug Revenue by Countries
5.1.1 North America Parkinson's Disease Drug Revenue by Countries (2019-2024)
5.2 North America Parkinson's Disease Drug Revenue by Types
5.3 North America Parkinson's Disease Drug Revenue by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Parkinson's Disease Drug Revenue by Countries
6.1.1 Asia Pacific Parkinson's Disease Drug Revenue by Countries (2019-2024)
6.2 Asia Pacific Parkinson's Disease Drug Revenue by Types
6.3 Asia Pacific Parkinson's Disease Drug Revenue by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Parkinson's Disease Drug Revenue by Countries
7.1.1 Europe Parkinson's Disease Drug Revenue by Countries (2019-2024)
7.2 Europe Parkinson's Disease Drug Revenue by Types
7.3 Europe Parkinson's Disease Drug Revenue by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Parkinson's Disease Drug Revenue by Countries
8.1.1 Latin America Parkinson's Disease Drug Revenue by Countries (2019-2024)
8.2 Latin America Parkinson's Disease Drug Revenue by Types
8.3 Latin America Parkinson's Disease Drug Revenue by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Parkinson's Disease Drug Revenue by Countries
9.1.1 Middle East & Africa Parkinson's Disease Drug Revenue by Countries (2019-2024)
9.2 Middle East & Africa Parkinson's Disease Drug Revenue by Types
9.3 Middle East & Africa Parkinson's Disease Drug Revenue by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Parkinson's Disease Drug Market Competition, by Players
10.1 Global Parkinson's Disease Drug Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Parkinson's Disease Drug Players Market Share in 2023
10.2.2 Top 6 Parkinson's Disease Drug Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Parkinson's Disease Drug Players Head Office, Business Provided
10.4 Parkinson's Disease Drug Mergers & Acquisitions
10.5 Parkinson's Disease Drug New Entrants and Expansion Plans
11 Players Profiles11.1 Merck
11.1.1 Merck Company Profile
11.1.2 Parkinson's Disease Drug Product Overview
11.1.3 Merck Parkinson's Disease Drug Market Performance (2019-2024)
11.1.4 Merck Business Overview
11.1.5 Recent Developments and Plans
11.2 Akorn
11.2.1 Akorn Company Profile
11.2.2 Parkinson's Disease Drug Product Overview
11.2.3 Akorn Parkinson's Disease Drug Market Performance (2019-2024)
11.2.4 Akorn Business Overview
11.2.5 Recent Developments and Plans
11.3 GSK
11.3.1 GSK Company Profile
11.3.2 Parkinson's Disease Drug Product Overview
11.3.3 GSK Parkinson's Disease Drug Market Performance (2019-2024)
11.3.4 GSK Business Overview
11.3.5 Recent Developments and Plans
11.4 Novartis
11.4.1 Novartis Company Profile
11.4.2 Parkinson's Disease Drug Product Overview
11.4.3 Novartis Parkinson's Disease Drug Market Performance (2019-2024)
11.4.4 Novartis Business Overview
11.4.5 Recent Developments and Plans
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Profile
11.5.2 Parkinson's Disease Drug Product Overview
11.5.3 Boehringer Ingelheim Parkinson's Disease Drug Market Performance (2019-2024)
11.5.4 Boehringer Ingelheim Business Overview
11.5.5 Recent Developments and Plans
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Company Profile
11.6.2 Parkinson's Disease Drug Product Overview
11.6.3 Teva Pharmaceutical Parkinson's Disease Drug Market Performance (2019-2024)
11.6.4 Teva Pharmaceutical Business Overview
11.6.5 Recent Developments and Plans
11.7 Abbvie
11.7.1 Abbvie Company Profile
11.7.2 Parkinson's Disease Drug Product Overview
11.7.3 Abbvie Parkinson's Disease Drug Market Performance (2019-2024)
11.7.4 Abbvie Business Overview
11.7.5 Recent Developments and Plans
11.8 Kyowa Hakko Kirin Pharma
11.8.1 Kyowa Hakko Kirin Pharma Company Profile
11.8.2 Parkinson's Disease Drug Product Overview
11.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Market Performance (2019-2024)
11.8.4 Kyowa Hakko Kirin Pharma Business Overview
11.8.5 Recent Developments and Plans
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Profile
11.9.2 Parkinson's Disease Drug Product Overview
11.9.3 Astellas Pharma Parkinson's Disease Drug Market Performance (2019-2024)
11.9.4 Astellas Pharma Business Overview
11.9.5 Recent Developments and Plans
11.10 Desitin Arzneimittel
11.10.1 Desitin Arzneimittel Company Profile
11.10.2 Parkinson's Disease Drug Product Overview
11.10.3 Desitin Arzneimittel Parkinson's Disease Drug Market Performance (2019-2024)
11.10.4 Desitin Arzneimittel Business Overview
11.10.5 Recent Developments and Plans
11.11 Endo Pharmaceuticals
11.11.1 Endo Pharmaceuticals Company Profile
11.11.2 Parkinson's Disease Drug Product Overview
11.11.3 Endo Pharmaceuticals Parkinson's Disease Drug Market Performance (2019-2024)
11.11.4 Endo Pharmaceuticals Business Overview
11.11.5 Recent Developments and Plans
12 Global Parkinson's Disease Drug Forecast Market Analysis by Type
12.1 Global Parkinson's Disease Drug Revenue Market Forecast by Type (2024-2030)
13 Global Parkinson's Disease Drug Forecast Market Analysis by Application
13.1 Parkinson's Disease Drug Revenue Market Forecast by Application (2024-2030)
14 Global Market Growth Forecast Analysis
14.1 Global Parkinson's Disease Drug Forecast Market Size (2024-2030)
14.2 Parkinson's Disease Drug Growth Trends Forecast Analysis by Regions
14.2.1 Parkinson's Disease Drug Revenue Forecast Market Size by Regions (2024-2030)
14.2.2 North America Parkinson's Disease Drug Forecast Market Size (2024-2030)
14.2.3 Europe Parkinson's Disease Drug Forecast Market Size (2024-2030)
14.2.4 Asia-Pacific Parkinson's Disease Drug Forecast Market Size (2024-2030)
14.2.5 Latin America Parkinson's Disease Drug Forecast Market Size (2024-2030)
14.2.6 Middle East & Africa Parkinson's Disease Drug Forecast Market Size (2024-2030)
15 Parkinson's Disease Drug Industry Dynamic Analysis
15.1 Parkinson's Disease Drug Market Trends Analysis
15.2 Parkinson's Disease Drug Market Drivers Analysis
15.3 Parkinson's Disease Drug Market Challenges Analysis
15.4 Parkinson's Disease Drug Market Restraints Analysis